PRE 14A

PRELIMININARY PROXY STATEMENT

Company: Protagenic Therapeutics, Inc.\new
Filed: September 15, 2011
Period of Report: September 15, 2011
Accession Number: 0001144204-11-053345

View Document ↗ View on SEC.gov ↗